In a recent study posted to the bioRxiv* pre-print server, researchers developed novel lipid nanoparticle (LNP)-based messenger ribonucleic acid (mRNA) vaccine formulations against three pathogenic ...
The researchers found that the primary composite reactogenicity outcome was noninferior in the simultaneous vs the sequential group. (HealthDay News) — Reactogenicity is comparable for simultaneous ...
About The Study: In this randomized clinical trial assessing simultaneous vs sequential administration of mRNA COVID-19 and inactivated influenza vaccines, reactogenicity was comparable in both groups ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback